Written question tabled by Jim Shannon (Democratic Unionist Party) on Tuesday, 15 September 2026, in the House of Commons for the Department of Health and Social Care. It is due for an answer on Monday, 12 October 2026.
Omaveloxolone
- Question
-
To ask the Secretary of State for Health and Social Care, what discussions her Department has had with Biogen regarding the company's withdrawal of its evidence submission to NICE for the appraisal of omaveloxolone for the treatment of Friedreich's ataxia.
Secondary information
- Type
- Written question
- Reference
- 29915
- Session
- 2026-27
- Subjects
- Biogen Omaveloxolone
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-17 13:56:17 +0100
- URI
- http://tabledpq.indexing.parliament.uk/commons/2026-27/29915
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://tabledpq.indexing.parliament.uk/commons/2026-27/29915
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://tabledpq.indexing.parliament.uk/commons/2026-27/29915